Targeting G Protein-Coupled Receptors with Biologics for Therapeutic Use, Part 2

摘要

In part 1, we summarized the advances made in new approaches developed to address the challenges of antigen generation for targeting G protein-coupled receptors (GPCRs). We reviewed the antibody and biologics pipeline with progress highlighted by someinteresting case studies on new targets (1). Here, we conclude by reviewing progress attained with other biologics.